NCT05976386 Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy Adults Status COMPLETED Phase PHASE1
NCT05976373 A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants. Status COMPLETED Phase PHASE1
NCT05976360 A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants Status COMPLETED Phase PHASE1
NCT05972629 A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05950750 Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study Status RECRUITING Phase N/A
NCT05922761 BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) Status RECRUITING Phase PHASE2
NCT05922501 Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma Status RECRUITING Phase PHASE2
NCT05911763 A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05908656 Implementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Data From Electronic Health Records (EHRs) in the United States (Project Searchlight) Status COMPLETED Phase NA
NCT05906706 Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid Status APPROVED_FOR_MARKETING Phase N/A
NCT05897424 Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05889221 Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase NA
NCT05878288 Deep sequencIng in Cutaneous Squamous CEll caRciNomas Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05876767 Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Doses of SAR444336 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05873205 Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05858788 A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants. Status COMPLETED Phase PHASE1
NCT05856331 Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema Status COMPLETED Phase PHASE2
NCT05849922 A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa Status COMPLETED Phase PHASE2